roscovitine drug
Evidence from:
primary |
all sources
Related entities (8)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| roscovitine | interacts_with | Cdk5 | — | 1 |
| roscovitine | targets | Cdk5 | — | 1 |
| roscovitine | interacts_with | cocaine | — | 1 |
| roscovitine | protective_against | conditioned place preference | — | 1 |
| roscovitine | risk_factor_for | locomotor sensitization | — | 1 |
| roscovitine | regulates | migration | — | 1 |
| roscovitine | regulates | motivation | — | 1 |
| roscovitine | protective_against | synaptic plasticity | — | 1 |
Mentioned in (4)
Papers in which this entity is mentioned.
- Assembly of functionally integrated human forebrain spheroids. (2017)
- CDK9-mediated transcription elongation is required for MYC addiction in hepatocellular carcinoma. (2014)
- CNVs: harbingers of a rare variant revolution in psychiatric genetics. (2012)
- Protein kinases and addiction. (2008)
Merged raw entities (3)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| roscovitine | drug | 4 | 11 |
| cdk5 inhibitor roscovitine | drug | — | — |
| seliciclib | drug | — | — |